Key facts
- RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13G/A for EyePoint Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (EYPT).
- Disclosed ownership: 4.7%.
- Date of event: 31 Dec 2024.
Key filing fact
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RA Capital Management, L.P. | 4.7% | 3,181,818 | 0 | 3,181,818 | /s/ Peter Kolchinsky | By Peter Kolchinsky, Authorized Signatory | |
| Peter Kolchinsky | 4.7% | 3,181,818 | 0 | 3,181,818 | /s/ Peter Kolchinsky | Peter Kolchinsky | |
| Rajeev Shah | 4.7% | 3,181,818 | 0 | 3,181,818 | /s/ Rajeev Shah | Rajeev Shah | |
| RA Capital Healthcare Fund, L.P. | 4.7% | 3,181,818 | 0 | 3,181,818 | /s/ Peter Kolchinsky | By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager |
CIK / CUSIP context first